DLA
MDLN

Douglas Lane & Associates’s Medline Inc MDLN Stock Holding History

Douglas Lane & Associates’s Portfolio MDLN Stock Details MDLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.16M Buy
+54,765
New +$2.21M 0.03% 150

Other funds holding MDLN

CG
Carlyle Group Washington, District of Columbia $10B AUM 10.61% 1-Year Est. Return
HFCIX
H&F Corporate Investors X San Francisco, California $2.8B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
LPC
Lone Pine Capital Greenwich, Connecticut $16.4B AUM 99.7% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Douglas Lane & Associates's MDLN Position: Q2 2026 in Review

Douglas Lane & Associates opened a new position in Medline Inc (MDLN) in Q2 2026: 54,765 shares worth $2.16M. The stake represents 0.03% of the portfolio and ranks #150 among its holdings.

406 funds tracked by Wall St. Rank hold MDLN as of Q2 2026.

  • Douglas Lane & Associates held 54,765 shares of Medline Inc worth $2.16M as of Q2 2026.
  • Medline Inc was a new Douglas Lane & Associates position in Q2 2026.
  • Medline Inc made up 0.03% of Douglas Lane & Associates's portfolio in Q2 2026, its #150 holding.
  • 406 funds tracked by Wall St. Rank held Medline Inc as of Q2 2026.

Based on Douglas Lane & Associates's 13F filing for Q2 2026, filed 14 Jul 2026.